Analytics

Addressing misconceptions as industry becomes more familiar with AI and ML.

Following a discussion around summarization in Part 1, Part 2 discusses the method of pure abstraction in light of recent advances in deep learning and AI.

Natural language processing can help simplify protocols of the past, as evidenced by a recent Novartis initiative.

Experimenting with different methods using AI.

Foundational issues must be addressed to advance best practices.

Poll taken by leading biotech executives in clinical development addresses state of data quality and management.

Chatbots can benefit regulatory landscape in light of evolving standards and guidelines.

Digital twins, defined as a typical demographic patient profile in a specific population, have the potential to help clinical trial design.

Study evaluates the use of AI-supported medical coding module.

Study designs, coupled with difficulties finding, enrolling and retaining trial participants, further intensify operational challenges and prevent new treatments from getting to market.

Explore how natural language processing and social graph techniques help to tackle the challenge of patient and investigator recruitment and raise the success rate of clinical trials.